Table 5 Preventive headache medication
Group | Substance | Number of patients (%) |
|---|---|---|
Antidepressants | Amitriptyline | 113 (8.4%) |
Opipramol | 10 (0.7%) | |
Amitriptylinoxide | 5 (0.4%) | |
Doxepin | 3 (0.2%) | |
Duloxetine | 11 (0.8%) | |
Venlafaxine | 14 (1.0%) | |
Antiepileptics | Topiramat | 71 (5.3%) |
Valproate | 2 (0.1%) | |
Betablockers | Bisoprolol | 16 (1.2%) |
Metoprolol | 83 (6.1%) | |
Propranolol | 8 (0.6%) | |
Botulinum neurotoxin | OnabotulinumtoxinA | 56 (4.2%) |
CGRP(R) antibodies | Erenumab | 73 (5.4%) |
Fremanezumab | 31 (2.3%) | |
Galcanezumab | 31 (2.3%) | |
Other substances | Flunarizine | 15 (1.1%) |
Candesartan | 13 (1.0%) | |
Lisinopril | 0 (0.0%) | |
Acetylsalicylic acid | 2 (0.1%) | |
Magnesium | 98 (7.3%) | |
Magnesium + vitamin B2 + coenzyme Q10 | 26 (1.9%) | |
Other | 75 (5.6%) |